Drugs affecting therapy with anticoagulants.
D000925:Anticoagulants / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000009:adverse effects; D002994:Clofibrate / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D003374:Coumarins / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D004232:Diuretics / Q000009:adverse effects; D004347:Drug Interactions; D004357:Drug Synergism; D064420:Drug-Related Side Effects and Adverse Reactions; D004967:Estrogens / Q000009:adverse effects; D000431:Ethanol / Q000009:adverse effects; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D012459:Salicylates / Q000009:adverse effects; D013974:Thyroxine / Q000009:adverse effects; D014044:Tolbutamide / Q000009:adverse effects; D014812:Vitamin K / Q000378:metabolism
D000925:Anticoagulants; D003276:Contraceptives, Oral; D003374:Coumarins; D004232:Diuretics; D004967:Estrogens; D006993:Hypnotics and Sedatives; D012459:Salicylates; D014812:Vitamin K; D000431:Ethanol; D010672:Phenytoin; D002701:Chloramphenicol; D006493:Heparin; D014044:Tolbutamide; D010653:Phenylbutazone; D002994:Clofibrate; D013974:Thyroxine